Indeed, the post-translational modifications of RyR2 observed in failing hearts have the potential to affect all RyR2 channels, in contrast to heterozygous CPVT patients in whom not all channels may be leaky. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.